Human genomics of acute liver failure due to hepatitis B virus infection: An exome sequencing study in liver transplant recipients.
Adult
Exome
/ genetics
Female
Genetic Predisposition to Disease
Genome, Human
Genomics
Hepatitis B
/ complications
Hepatitis B Antibodies
/ blood
Humans
Liver Failure, Acute
/ genetics
Liver Transplantation
/ statistics & numerical data
Male
Middle Aged
Risk Factors
Sequence Analysis, DNA
Transplant Recipients
/ statistics & numerical data
Young Adult
acute liver failure
exome sequencing
fulminant hepatitis
hepatitis B virus
Journal
Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
07
07
2018
revised:
05
09
2018
accepted:
10
09
2018
pubmed:
14
10
2018
medline:
27
6
2020
entrez:
14
10
2018
Statut:
ppublish
Résumé
Acute liver failure (ALF) or fulminant hepatitis is a rare, yet severe outcome of infection with hepatitis B virus (HBV) that carries a high mortality rate. The occurrence of a life-threatening condition upon infection with a prevalent virus in individuals without known risk factors is suggestive of pathogen-specific immune dysregulation. In the absence of established differences in HBV virulence, we hypothesized that ALF upon primary infection with HBV could be due to rare deleterious variants in the human genome. To search for such variants, we performed exome sequencing in 21 previously healthy adults who required liver transplantation upon fulminant HBV infection and 172 controls that were positive for anti-HBc and anti-HBs but had no clinical history of jaundice or liver disease. After a series of hypothesis-driven filtering steps, we searched for putatively pathogenic variants that were significantly associated with case-control status. We did not find any causal variant or gene, a result that does not support the hypothesis of a shared monogenic basis for human susceptibility to HBV-related ALF in adults. This study represents a first attempt at deciphering the human genetic contribution to the most severe clinical presentation of acute HBV infection in previously healthy individuals.
Substances chimiques
Hepatitis B Antibodies
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
271-277Informations de copyright
© 2018 John Wiley & Sons Ltd.